Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SORD inhibitors(Sorbitol dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H26N6O2 |
InChIKeyATNZXIACLONSSN-XJFOESAGSA-N |
CAS Registry300548-99-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Neuropathies | Preclinical | US | 01 Jun 2002 |